For research use only. Not for therapeutic Use.
OPB-51602 is a small-molecule inhibitor of the signal transducer and activator of transcription 3 (STAT3) pathway, which is involved in promoting cancer cell survival, proliferation, and immune evasion. By targeting and inhibiting STAT3 signaling, OPB-51602 disrupts critical oncogenic processes, making it a promising candidate for cancer research. It has demonstrated efficacy against a range of tumors, including those resistant to traditional therapies, by inducing apoptosis and reducing tumor growth. OPB-51602 is being explored for its potential in treating cancers such as leukemia, lymphoma, and solid tumors where STAT3 is aberrantly activated.
| Catalog Number | I008474 |
| Synonyms | OPB51602; OPB 51602; OPB51602.;NONE |
| Purity | ≥95% |
| Target | STAT3 inhibitor |
| Solubility | Soluble in DMSO, not in water |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
